Statement of Changes in Beneficial Ownership (4)
September 21 2018 - 05:08PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Blaser Brian J
|
2. Issuer Name
and
Ticker or Trading Symbol
ABBOTT LABORATORIES
[
ABT
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Executive Vice President
|
(Last)
(First)
(Middle)
100 ABBOTT PARK ROAD
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
9/20/2018
|
(Street)
ABBOTT PARK, IL 60064-6400
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common shares without par value
|
9/20/2018
|
|
M
|
|
48100
|
A
|
$27.0336
|
184918
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
M
|
|
10100
|
A
|
$29.2920
|
195018
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
900
|
D
|
$68.73
|
194118
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
350
|
D
|
$68.735
|
193768
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
100
|
D
|
$68.7375
|
193668
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
1800
|
D
|
$68.74
|
191868
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
1250
|
D
|
$68.745
|
190618
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
800
|
D
|
$68.75
|
189818
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
2043
|
D
|
$68.755
|
187775
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
1757
|
D
|
$68.76
|
186018
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
1837
|
D
|
$68.765
|
184181
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
3020
|
D
|
$68.77
|
181161
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
3822
|
D
|
$68.775
|
177339
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
2400
|
D
|
$68.78
|
174939
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
2300
|
D
|
$68.785
|
172639
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
7807
|
D
|
$68.79
|
164832
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
1100
|
D
|
$68.795
|
163732
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
1500
|
D
|
$68.80
|
162232
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
1442
|
D
|
$68.805
|
160790
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
4522
|
D
|
$68.81
|
156268
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
1136
|
D
|
$68.815
|
155132
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
5800
|
D
|
$68.82
|
149332
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
2000
|
D
|
$68.825
|
147332
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
6240
|
D
|
$68.83
|
141092
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
960
|
D
|
$68.835
|
140132
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
3214
|
D
|
$68.84
|
136918
|
D
|
|
Common shares without par value
|
9/20/2018
|
|
S
|
|
100
|
D
|
$68.845
|
136818
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Option (right to buy)
(1)
|
$27.0336
|
9/20/2018
|
|
M
|
|
|
48100
|
2/17/2015
|
2/16/2022
|
Common shares
|
48100
|
$0
|
0
|
D
|
|
Option (right to buy)
(1)
|
$29.2920
|
9/20/2018
|
|
M
|
|
|
10100
|
6/1/2015
|
5/31/2022
|
Common shares
|
10100
|
$0
|
0
|
D
|
|
Explanation of Responses:
|
(1)
|
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
|
Remarks:
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Blaser Brian J
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-6400
|
|
|
Executive Vice President
|
|
Signatures
|
Jessica H. Paik, by power of attorney for Brian J. Blaser
|
|
9/21/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2023 to Mar 2024